ダイト(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4577/E24187 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2020/04/24 | 日証協 | 284,326株 | +0.84% | 42,000株 | -32.34% | 305,318株 | -2.9% | 17,603株 | -30.7% |
2020/04/17 | 日証協 | 281,944株 | -33.3% | 62,076株 | -53.43% | 314,452株 | -29.88% | 25,400株 | -11.05% |
2020/04/10 | 日証協 | 422,726株 | -13.18% | 133,309株 | +187.92% | 448,418株 | -9.98% | 28,556株 | +106.12% |
2020/04/03 | 日証協 | 486,876株 | +0.44% | 46,300株 | -80.76% | 498,158株 | -1% | 13,854株 | -93.42% |
2020/03/27 | 日証協 | 484,726株 | +70.49% | 240,600株 | +1056.73% | 503,208株 | +59.51% | 210,700株 | +588.09% |
2020/03/19 | 日証協 | 284,315株 | +5.88% | 20,800株 | -88.98% | 315,480株 | +11.8% | 30,621株 | -77.63% |
2020/03/13 | 日証協 | 268,515株 | +56.04% | 188,673株 | +1238.11% | 282,189株 | +62.14% | 136,863株 | +456.13% |
2020/03/06 | 日証協 | 172,081株 | -2.59% | 14,100株 | -55.51% | 174,039株 | +10.08% | 24,610株 | +18.58% |
2020/02/28 | 日証協 | 176,653株 | +17.61% | 31,689株 | +115.72% | 158,097株 | +4.77% | 20,754株 | +33.9% |
2020/02/21 | 日証協 | 150,203株 | +3.53% | 14,690株 | +234.62% | 150,897株 | -0.58% | 15,500株 | +106.67% |
2020/02/14 | 日証協 | 145,082株 | +0.35% | 4,390株 | -72.56% | 151,776株 | +1.8% | 7,500株 | -48% |
2020/02/07 | 日証協 | 144,582株 | -1.82% | 16,000株 | +133.27% | 149,088株 | -0.13% | 14,424株 | +111.37% |
2020/01/31 | 日証協 | 147,262株 | +1.05% | 6,859株 | -79.01% | 149,288株 | +1.55% | 6,824株 | -66.94% |
2020/01/24 | 日証協 | 145,737株 | +9.09% | 32,680株 | -66.58% | 147,015株 | +7.58% | 20,641株 | +59.85% |
2020/01/17 | 日証協 | 133,597株 | +7.46% | 97,799株 | +9999.99% | 136,662株 | +3.47% | 12,913株 | -40.79% |
2020/01/10 | 日証協 | 124,319株 | -6.95% | 730株 | -79.14% | 132,082株 | +3.94% | 21,810株 | +473.95% |
2019/12/30 | 日証協 | 133,599株 | -2.27% | 3,500株 | -70.06% | 127,077株 | -2.31% | 3,800株 | -63.48% |
2019/12/27 | 日証協 | 136,709株 | -2.22% | 11,689株 | -55.35% | 130,077株 | -5.68% | 10,406株 | -11.81% |
2019/12/20 | 日証協 | 139,811株 | -7.99% | 26,178株 | +182.73% | 137,909株 | -8.55% | 11,800株 | +76.01% |
※株式分割は考慮していませんのでご注意ください。
Page Top